TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 192 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2021. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $11,925,000 | -48.7% | 250,000 | -28.6% | 0.32% | -37.7% |
| Q3 2021 | $23,251,000 | -14.9% | 350,000 | 0.0% | 0.52% | -6.1% |
| Q2 2021 | $27,307,000 | -7.7% | 350,000 | +11.9% | 0.55% | +5.9% |
| Q1 2021 | $29,578,000 | -30.6% | 312,700 | -10.7% | 0.52% | -42.9% |
| Q4 2020 | $42,648,000 | +50.2% | 350,000 | +7.7% | 0.92% | +32.9% |
| Q3 2020 | $28,392,000 | +25.6% | 325,000 | -7.1% | 0.69% | +8.8% |
| Q2 2020 | $22,607,000 | +68.7% | 350,000 | +16.7% | 0.63% | +11.8% |
| Q1 2020 | $13,398,000 | -28.3% | 300,000 | 0.0% | 0.57% | -21.6% |
| Q4 2019 | $18,687,000 | +24.2% | 300,000 | -25.0% | 0.72% | +19.7% |
| Q3 2019 | $15,040,000 | +84.8% | 400,000 | +100.0% | 0.60% | +83.3% |
| Q2 2019 | $8,140,000 | – | 200,000 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 708,233 | $44,116,000 | 18.91% |
| Corriente Advisors, LLC | 285,000 | $17,753,000 | 9.54% |
| Cormorant Asset Management, LP | 3,396,650 | $211,577,000 | 8.44% |
| Opaleye Management Inc. | 340,500 | $21,210,000 | 4.16% |
| Orbimed Advisors | 2,745,327 | $171,006,000 | 2.44% |
| Parkman Healthcare Partners LLC | 101,434 | $6,318,000 | 1.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,179,000 | 0.78% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 366,000 | $22,798,000 | 0.73% |
| Artal Group S.A. | 300,000 | $18,687,000 | 0.72% |
| DAFNA Capital Management LLC | 30,408 | $1,894,000 | 0.65% |